Latest Breaking News On - Tiffany farchione - Page 1 : vimarsana.com

Interest in Psilocybin Continues to "Mushroom" for Potential Mental Health Treatment | McGuireWoods LLP

Interest in the potential for psilocybin to be developed as a mental health treatment has continued to grow in recent months, due in part to recent activity by the U.S. Food and Drug...

La Jolla resident's new book explores unconventional paths to trauma recovery

Melissa Osorio says she was able to unlock 13 years of repressed memories and hopes the book can help others with their own experiences.

Drug Maker Says Women Can Now Access Postpartum Depression Pill

Zurzuvae (zuranolone), the first postpartum depression pill approved for use in the United States, is now available to women who need it.

Drug Maker Says Women Can Now Access Postpartum Depression Pill

Zurzuvae (zuranolone), the first postpartum depression pill approved for use in the United States, is now available to women who need it.

Pill to treat postpartum depression now available in pharmacies

The first postpartum depression pill approved for use in the United States is now available to women who need it, the drug's makers announced Thursday.

Postpartum depression pill now available to women, drug maker says

First postpartum Depression Pill Now Available to Women, Company Says

The first oral pill approved in the United States to treat postpartum depression is now available by prescription, according to the drugmakers.

Psychedelic productivity: Can microdosing psilocybin boost your performance at work?

Can microdosing psilocybin, also known as magic mushrooms, play a positive role in the workplace? One business executive turned microdosing expert says yes.

Men can also experience postpartum depression. Dads share what it's like.

What new research shows — and what experts say men can do to get support.

GUEST EDITORIAL: Postpartum depression drug a good beginning

It is difficult to overstate the importance of the announcement earlier this month that the Food and Drug Administration approved the nation’s first antidepressant aimed at treating postpartum depression.